Please complete this short form to get in touch with a member of our team and we will get back to you as soon as we can.
National segmentation resources, produced by the Population and Person Insight project, are helping to build the foundations for wider population health and person-centred analytics. Find out more about the project and resources on a dedicated Future NHS workspace.
Experts from Arden & GEM’s digital transformation and business intelligence teams will be presenting as part of a week of programmes run by Health Tech Newspaper (HTN).
Mark Smith has been appointed as NHS Arden & GEM Commissioning Support Unit’s new Director of Finance, bringing 20 years of senior financial leadership experience within the healthcare sector.
Arden & GEM’s Data and Systems team has been named winners in the Patient Data category at the Health Business Awards 2020 for the COVID-19 Patient Notification System.
As part of Arden & GEM's commitment to continuous improvement, our IT service is rolling out a series of developments designed to improve our customer’s IT experience.
Arden & GEM has been successfully shortlisted in the ‘Patient Data’ and ‘Telehealth’ categories at the Health Business Awards 2020.
A new national programme has been launched to work closely with a series of pilot sites, using population health approaches and multidisciplinary partnerships, to identify and tackle local health inequality challenges.
Arden & GEM and NHS England Highly Specialised Commissioning have been named winners of the Health Care Supply Association (HCSA) Cross Functional Collaboration Award 2020.
Arden & GEM’s Data and Systems team has rapidly developed a national system to capture data on administered vaccinations to inform management of the 2020/21 flu immunisation programme and underpin a future COVID vaccination programme.
Arden & GEM’s medicines optimisation team has had an article published in the latest issue of the Journal of Pharmacy Management, covering an innovative project to accelerate the uptake of biosimilars with a high cost drugs in-reach pharmacist.